As of 11:54am ET
| +0.175 / +2.24%|
The 4 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 11.63, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +45.31% increase from the last price of 8.00.
The current consensus among 4 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.